Recent Finacing
Recent Raise
Taligen Therapeutics is a Cambridge, MA biotech developing complement-regulating therapeutics, advancing lead candidate TT30 toward clinical trials and pursuing complement inhibitor programs for PNH, AMD, and transplant-related inflammation.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors